Awarded contract
Provision of Stem Cells & Blood Products
Details
- Supplier(s)
- Anthony Nolan
- Value
- GBP 1,500,000
- Duration
- 11 months
- Topic
- Blood products
- Published
- 11 May 2026
- Source
- uk:find_a_tender
Tender description
Provision of stems cells and blood products in a specialist area of expertise, items to be purchased direct based on patient requirement. ## Contract award Title: Provision of Stem Cells and Blood Products ## Contract award
Timeline
- Completed: Award published11 May 2026Current notice
- Completed: Award date11 May 2026
- Next: Contract expiry date31 March 2027in 7 months
About the buyer
The Clatterbridge Cancer Centre NHS Foundation Trust is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33141510 · Blood products
- 33141570 · Human blood
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@the-clatterbridge-cancer-centre-nhs-foundation-trust.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@the-clatterbridge-cancer-centre-nhs-foundation-trust.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@the-clatterbridge-cancer-centre-nhs-foundation-trust.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@the-clatterbridge-cancer-centre-nhs-foundation-trust.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@the-clatterbridge-cancer-centre-nhs-foundation-trust.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@the-clatterbridge-cancer-centre-nhs-foundation-trust.gov |
Related buyers
Buyers similar to The Clatterbridge Cancer Centre NHS Foundation Trust.
BuyersCountValue
- 514£239.2m
- 381£5.3bn
- 262£44.9m
- 244£140.9m
- 231£25.7m
- 229£225.2m
- 220£11.8m
- 209£131.5m
- 178£11.5bn
- 178£46.5m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
